Clinical Trial

Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance.

Study acronym: A-GPC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 9, 2026 (before its estimated May 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.
Trial Details
NCT Number NCT07397273
Lead Sponsor Northern Illinois University
Collaborators: Mayo Clinic
Conditions Healthy Adult Participants
Enrollment 20 participants
Start Date 2026-03-16
Primary Completion 2026-05-16 (estimated)
Study Completion 2026-05-16 (estimated)
Updated on ClinicalTrials.gov 2026-02-09